And MED Inc. 2026

Aichi, Nagoya City

With the mission of “Connecting Healthcare,” AndMED Co., Ltd. aims to create better healthcare experiences and value by bridging the gaps between patients and healthcare, society and healthcare, and technology and healthcare. By combining the CEO’s insights gained from working on the front lines as a cardiovascular surgeon with a management perspective cultivated through medical research, patient safety, and an MBA, the company is engaged in healthcare consulting, education and training, medical technology evaluation, and healthcare digital transformation (DX). Currently, the company has developed “DOUSEKI,” an AI-powered medical explanation platform that uses AI to record and organize doctors’ explanations, thereby supporting patients’ and their families’ understanding and acceptance. Through this, the company aims to realize a healthcare system where both healthcare providers and patients can make better decisions.

And MED Inc.'s Main Innovation
INNOVATION

Digital Transformation in Healthcare Through an AI Platform for Medical Explanations

In this study, we are working on the development and validation of “DOUSEKI (Present at the Meeting),” an AI-powered medical explanation platform that records, summarizes, and structures explanations provided by physicians regarding medical conditions and treatment plans, thereby supporting patients’ and their families’ understanding and acceptance. By utilizing speech recognition and large language models (LLMs), the platform organizes the content of these explanations, converts technical terms into plain language, and integrates information such as consent forms and clinical guidelines to assist in confirming key points and assessing the level of understanding. Through a proof of concept (PoC) in clinical settings, we will verify whether the platform can simultaneously improve patients’ understanding and acceptance while streamlining physicians’ explanation and documentation tasks, with the goal of implementing a system that enables both patients and healthcare providers to make better decisions.

Spread the Word

And MED Inc. Representative Introduction
REPRESENTATIVE

Representative Toshiyuki Yamada Toshiyuki Yamada
Representative Director and CEO of And MED Co., Ltd. Cardiovascular surgeon, Doctor of Medicine, MBA. After graduating from Nagoya City University School of Medicine, he has been engaged in clinical practice, research, and education as a cardiovascular surgeon. He earned his Doctor of Medicine (M.D.) from the Graduate School of Medicine at Keio University and his MBA from Globis Graduate School of Management. He has also been involved in healthcare safety management. While continuing his clinical practice in the Department of Cardiovascular Surgery at Hamamatsu University School of Medicine, he founded And MED Co., Ltd. to solve challenges in the healthcare field through the power of technology and business. He is working to implement healthcare solutions in society by bridging the gaps between clinical practice, research, and management.
Main Achievements 2026: Founded AndMED Co., Ltd.
2026: Finalist in G-CHALLENGE by GLOBIS 2025
2025: Vice Chair of “Opsul 2025,” organized by the Japanese Society of Surgery
2023–present: Conducted multiple Grant-in-Aid for Scientific Research and industry-academia collaborative research projects in the fields of healthcare ICT, digital transformation (DX), and patient safety
2023: Activities related to medical education featured in the Yomiuri Shimbun, TBS Radio, and other media outlets
Influential People, Things, and Events People: “The diverse individuals and colleagues I’ve met in medical settings, universities, graduate schools, and business schools”
Things: “New technologies that are transforming healthcare and society”
Issues: “Unresolved challenges I’ve encountered in the clinical setting of cardiovascular surgery”
Motivation, Goals, and Ideal World Working on the front lines as a cardiovascular surgeon, I have come to realize that there are many challenges in healthcare that can only be seen from within the clinical setting. At the same time, simply researching these challenges and publishing papers about them does not necessarily bring about change in society. I have been engaged in research on surgical education, digital transformation in healthcare, and patient safety, and have also sought to implement these findings in society through crowdfunding and collaborative research with companies. Based on this experience, I recognized the need for a system that takes ideas born on the front lines of healthcare, researches them, and delivers them to society as business ventures—which led me to establish AndMED, Inc.
“DOUSEKI,” which we are currently developing, also stems from challenges I’ve observed during surgical consultations. Even when doctors explain things as thoroughly as possible, it is difficult for patients to understand all the technical terms and vast amounts of information on the spot. I believe that if AI can “attend” the doctor’s explanation, record and organize the content, and allow patients and their families to review it later, we can bridge the gap between the doctor’s assumption that they have explained something and the patient’s assumption that they have understood it.
My goal is to create a world where healthcare, technology, and business are interconnected—so that challenges identified on the front lines do not end as mere research but are implemented in society as sustainable services. I aim to develop systems that bring greater happiness to everyone involved in healthcare, starting from the clinical setting.

And MED Inc. Basic Informaton
BASIC
INFORMATION

Company Name And MED Inc.
Representative Name Toshiyuki Yamada
Address 4-24-5 Meieki, Nakamura Ward, Nagoya City, Aichi Prefecture, Room 401, Dai-2 Mori Building
Official Site and Social Media, etc. Official Website
Founding Date March 15, 2026
Awards 2018: KBS × Gunosy Chairman’s Cup 2018—Winner (Gunosy Award)
2026: G-CHALLENGE by GLOBIS 2025—Finalist
2026: Selected for the Reiwa 8 ICT Startup League

For more details on STARTUP LEAGUE's startup support,
please see here.